Subscribe To
GENFF / Genflow Biosciences primed and ready for phase I/II trial after regulatory sign-off
GENFF News
By Proactive Investors
September 28, 2023
Genflow Biosciences well-funded for next R&D milestones
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) said it is funded until at least March 2025 as it summarised the significant progress it has made in t more_horizontal
By Proactive Investors
September 20, 2023
Genflow Biosciences primed and ready for phase I/II trial after regulatory sign-off
Genflow Biosciences PLC (LSE:GENF, OTC:GENFF) said it has received encouraging advice from Belgium's Federal Agency for Medicines and Health Products more_horizontal
By Proactive Investors
September 19, 2023
Genflow Biosciences CEO Reveals the Secrets of Longevity: An Exclusive Interview with Dr Eric Leire
In conversation with Dr Eric Leire, chief executive of Genflow Biosciences, we delve into the company's groundbreaking work in the field of longevity. more_horizontal